Patents by Inventor Daniel Dauch

Daniel Dauch has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200000787
    Abstract: The invention provides a pharmaceutical composition comprising Sorafenib in combination with an inhibitor of a specific kinase inhibitor as a medicament for the treatment or prevention of liver cancer.
    Type: Application
    Filed: September 12, 2019
    Publication date: January 2, 2020
    Applicant: HELMHOLTZ-ZENTRUM FUER INFEKTIONSFORSCHUNG GmbH
    Inventors: Lars Zender, Ramona Rudalska, Daniel Dauch
  • Patent number: 10441577
    Abstract: The invention provides a pharmaceutical composition comprising Sorafenib in combination with an inhibitor of a specific kinase inhibitor as a medicament for the treatment or prevention of liver cancer.
    Type: Grant
    Filed: July 9, 2012
    Date of Patent: October 15, 2019
    Assignee: HELMHOLTZ ZENTRUM FUER INFEKTIONSFORSCHUNG
    Inventors: Lars Zender, Ramona Rudalska, Daniel Dauch
  • Publication number: 20150079154
    Abstract: The invention provides a pharmaceutical composition comprising Sorafenib in combination with an inhibitor of a specific kinase inhibitor as a medicament for the treatment or prevention of liver cancer.
    Type: Application
    Filed: July 9, 2012
    Publication date: March 19, 2015
    Applicant: HELMHOLTZ-ZENTRUM FUER INFEKTIONSFORSCHUNG GMBH
    Inventors: Lars Zender, Ramona Rudalska, Daniel Dauch